Press Release: Assembly Biosciences Presents Data Highlighting Recurrent Genital Herpes Program at STI & HIV 2025 World Congress and International Herpesvirus Workshop
– Phase 1a clinical data in healthy participants presented for both ABI-5366 and ABI-1179, novel long-acting herpes simplex virus helicase-primase inhibitor candidates – – Preclinical data and U.S. genital herpes prevalence and treatment patterns also highlighted –
Sacramento, CA , Jan. 19, 2026 (GLOBE NEWSWIRE) -- Jatagan Security, a pioneer in outdoor video security services with over 20 years of industry leadership, today announced its 2025 crime prevention success rate of 99.94% (6 misses out of 10,000 incidents), reaffirming its position as the benchmark for outdoor security performance across Northern California and…
LOS ANGELES, Jan. 19, 2026 (GLOBE NEWSWIRE) -- URBANICA Furniture today introduced its Bistro Table, a round bistro table designed for modern spaces where one surface often has to do it all, from everyday dining to quick laptop sessions and small group conversations. The product is labeled Sustainably Made and BIFMA certified on URBANICA’s product…
TORONTO, Jan. 19, 2026 (GLOBE NEWSWIRE) -- Support Staff for the Elementary Teachers’ Federation of Ontario have entered the second week of their strike. A public Rally for Respect is planned for Thursday January 22 at noon.
Seoul, Jan. 19, 2026 (GLOBE NEWSWIRE) -- Mocomtech Co., Ltd. announced the U.S. availability of Real 3D Israel’s Sacred Pilgrimage, a screen-free Real 3D pilgrimage experience created for people who cannot easily visit Jerusalem and the Holy Land, those who hope to go but face distance, cost, or physical limitations, and churches and Christian education…
LOS ANGELES, Jan. 19, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Quantum Corporation, (“Quantum” or the "Company") (NASDAQ: QMCO) investors of a class action on behalf of investors that bought securities between November 15, 2024 and August 18, 2025, inclusive (the “Class Period”). Quantum investors have until November 3, 2025 to file a lead plaintiff…
